These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3415808)

  • 1. Lack of increase in sodium concentration of cerebrospinal fluid in DOCA-salt hypertensive rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):45S-48S. PubMed ID: 3415808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of increase in concentrations of cerebrospinal fluid sodium in rats with various stages of DOCA-salt hypertension.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Life Sci; 1988; 42(12):1223-9. PubMed ID: 3347147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Exp Hypertens A; 1988; 10(2):203-27. PubMed ID: 3370846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral mechanisms of the enhanced hypertension following long-term salt loading in spontaneously hypertensive rats.
    Takata Y; Yamashita Y; Takishita S; Tsuchihashi T; Tomita Y; Kimura Y; Koga T; Fujishima M
    Jpn Circ J; 1988 Nov; 52(11):1317-22. PubMed ID: 3225897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid sodium and enhanced hypertension in salt-loaded spontaneously hypertensive rats.
    Yamashita Y; Takata Y; Takishita S; Tomita Y; Tsuchihashi T; Fujishima M
    J Hypertens; 1992 Aug; 10(8):741-7. PubMed ID: 1325505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R; St-Louis J; Schiffrin EL
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
    Stallone JN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
    Morton JJ; Garcia del Rio C; Hughes MJ
    Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats.
    Mimura Y; Ogura T; Yamauchi T; Otsuka F; Oishi T; Harada K; Hashimoto M; Ota Z
    Acta Med Okayama; 1995 Aug; 49(4):187-94. PubMed ID: 7502678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats.
    Berecek KH; Mah SC; Baum P; Hofbauer KG
    J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats.
    Klarr SA; Keep RF; Betz AL
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H646-52. PubMed ID: 7864190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypertensinogenic activity of 18,19-dihydroxycorticosterone in adrenalectomized rats.
    Fragman S; Harnik M; Peleg E; Zamir N; Rosenthal T
    Am J Hypertens; 1992 Jun; 5(6 Pt 1):399-401. PubMed ID: 1524765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of mineralocorticoid activity of aldosterone by 18-hydroxy-corticosterone and 18-hydroxy-19-nor-corticosterone in adrenalectomized rats.
    Rosenthal T; Shani M; Peleg E; Harnik M
    Endocr Res; 1990; 16(2):185-91. PubMed ID: 2344835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the sympathetic nervous system and vasopressin on the blood pressure lowering effect of nifedipine in deoxycorticosterone acetate-salt hypertensive rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Sci (Lond); 1987 Sep; 73(3):253-8. PubMed ID: 3652632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.